Riverain Medical has announced the results of a European study which compared the company’s OnGuard 1.0 and OnGuard 5.1 computer-aided detection (CAD) technologies, which work with standard chest x-rays to improve detection of pulmonary nodules and reduce the rate of false positives. The study proved OnGuard 5.1’s superiority over the older version, and results were published on the European Society of Radiology’s website in the form of a poster presentation titled “A Superior Chest X-Ray Computer-Aided Detection (CXR CADe) Application: A Reader Study”.
“By using OnGuard 5.1 in tandem with a standard chest X-ray, our radiologists are now able to detect smaller lung nodules that would have previously gone unnoticed,” said Dr. Matthew Freedman, principal investigator of the study and Associate Professor of oncology at the Lombardi Comprehensive Cancer Center at Georgetown University in Washington, D.C. “It’s clear from our research that OnGuard CAD technology has improved significantly over the past 10 years. Improved sensitivity and a lower false positive rate allow radiologists to detect early-stage lung cancer sooner, giving them more confidence in diagnosing the patient.”
Product page: OnGuard…
Link: Study Shows Improved Detection of Lung Cancer Nodules with Riverain Medical’s CAD Chest X-ray Technology…
Flashbacks: Radiologists Get Software Assistance for Chest X-Ray Analysis; Riverain’s Updated Chest X-Ray CAD Technology Gets FDA OK